# INTERCEPTA Phase B — Phase 8 Audit Report

**Status:** AUDIT COMPLETE; verdict PROVISIONAL PASS WITH 4 DRIFT FINDINGS for CEO review + cleanup before Layer 5 starts
**Date:** 2026-05-11
**Author:** Claude (CSO)
**Subject of audit:** All 10 Phase B Layer 2-4 specifications (~71K words)
**Methodology:** 8-pass deep read per audit plan §0; pattern matches the 2026-05-11 Charter v1.2 audit that surfaced 11 drift findings
**Filename:** INTERCEPTA_Phase_B_Phase_8_Audit_Report_2026-05-11.md

---

## §0 Audit Methodology

### 0.1 Why a Phase 8 Audit

Per Phase B Plan v2 + Charter §10 P15 BINDING: the architectural specs across 10 sessions and ~71K words can contain subtle contradictions that only become visible when read together. The 2026-05-11 audit of the Charter v1.1 corpus surfaced 11 drift findings; the Phase B Layer 2-4 corpus is larger and the same pattern is expected.

The audit is NOT a re-architecture. It does NOT propose changes; it surfaces inconsistencies for CEO+CSO joint decision on whether to revise specs or accept caveats before Layer 5 starts.

### 0.2 The 8-Pass Methodology

| Pass | Focus | What it catches |
|---|---|---|
| 1 | BINDING constraint inventory | Inconsistent BINDING values across specs |
| 2 | Cross-decision implications symmetry | Spec X cites Decision Y but Decision Y doesn't reciprocate |
| 3 | Schema and interface coherence | L7Output / OODOutput / InterpretabilityOutput / CascadeReport mismatch between producer and consumer |
| 4 | CSO judgment item escalation review | Items touching strategy assigned to CSO; items technical assigned to CEO |
| 5 | Compute envelope arithmetic | Sum of per-stage estimates vs Decision 9 v2 budget |
| 6 | Test coverage completeness | Every BINDING contract has ≥1 property test |
| 7 | Failure mode coverage | Every L4.1 handoff failure path appears in L4.3 detection matrix |
| 8 | Charter principle compliance | P3 / P15 / P16 honored in every spec |

### 0.3 Subjects Audited

10 Phase B specs (Layer 2-4) totaling ~71,063 words:

| Spec | Status | Words |
|---|---|---|
| L2.1 Substrate | LOCKED | 9,693 |
| L2.2 L7 Drug Response | PROPOSED | 12,885 |
| L2.3 OOD Stack | PROPOSED | 8,423 |
| L2.4 Interpretability | PROPOSED | 10,950 |
| L3.1 Validation Pipeline | PROPOSED | 4,311 |
| L3.2 56 Pass Criteria | PROPOSED | 5,579 |
| L3.3 V6 Grid | PROPOSED | 5,022 |
| L4.1 Implementation Order | PROPOSED | 4,858 |
| L4.2 Testing | PROPOSED | 4,327 |
| L4.3 Failure Modes | PROPOSED | 4,645 |
| **Total** | | **71,063** |

---

## §1 Audit Findings Summary

### 1.1 Overall Verdict

**PROVISIONAL PASS** — the 10 specs are internally consistent on the major BINDING constraints (Souza-Mehta ≥25%, V3 AUROC 0.77, V4 RMSE 0.11 TNBC, V5 ECE 0.05, V6 ≥0.65 on ≥2 areas, Drift Findings 7/8/10, schema coherence) but **4 new drift findings (D12-D15) require cleanup before Layer 5 starts.**

### 1.2 Drift Findings This Audit (D12-D15)

| ID | Severity | Issue | Action |
|---|---|---|---|
| **D12** | MEDIUM | L4.1 Stage 4 deliverables list MoLFormer Slot 2 but omit BINDING RDKit ≥25% matched baseline from L2.2 §3.4 | L4.1 cleanup: add RDKit baseline to Stage 4 deliverables |
| **D13** | HIGH | L2.2 spec defines `ensemble_random_seeds = [0,1,2,3,4]` but L4.1 + L4.2 specify `{42, 1337, 2023, 9, 31337}` citing "Drift Finding 8" | Resolve which is canonical; amend the non-canonical spec |
| **D14** | HIGH | L3.3 §3.2 commits to EVA-60M for paradigm B (UC) but L4.1 Stage 3 §4.2 deliverables list only 4 substrate adapters (no EVA) | L4.1 cleanup: add EVA-60M adapter to Stage 3 OR L3.3 amendment to defer EVA |
| **D15** | LOW | L3.1 V1 assumes "harmonization upstream; inherits harmonized data" but L4.1 defers full Decision 2 v2 to "future Layer 4 spec" | Verify L4.1 §3.3 placeholder is sufficient for V1; if not, schedule Decision 2 v2 deep spec before Stage 7 |

### 1.3 What the Audit Did NOT Find

- ❌ No contradictions in primary threshold values (V3 0.77, V4 0.11, V5 0.05, V6 0.65 uniform)
- ❌ No L7Output schema mismatches between L2.2 producer and L2.4 consumer
- ❌ No OODOutput verdict schema mismatch between L2.3 producer and L2.4 consumer
- ❌ No compute envelope overrun (L3.3 V6 ~104 GPU-days within L4.1's 100-200 range; total 174-224 within 200-300 envelope)
- ❌ No Drift Finding 7/8/10 inconsistency (architectural identities preserved consistently)
- ❌ No Phase F scope creep (anti-creep enforced uniformly)

---

## §2 Drift Finding D12 — L4.1 Stage 4 Missing RDKit Slot 2 Baseline

### 2.1 What L2.2 Requires (BINDING)

L2.2 §3.4 explicitly BINDING per Decision 8 v2 Commitment 5:

> "RDKit baseline — non-learned molecular fingerprints (Morgan/Avalon/MACCS). The 'parameter-free baseline' for Slot 2, analogous to Souza-Mehta scTOP for Slot 1. **BINDING per Decision 8 v2 Commitment 5: this baseline must receive ≥25% of MoLFormer's hyperparameter search budget.**"

This makes Slot 2's matched-pair Souza-Mehta baseline architecturally REQUIRED, not optional.

### 2.2 What L4.1 Stage 4 Specifies

L4.1 §5.2 Stage 4 deliverable 4.3:

> "4.3 `intercepta.l7.slots.molformer.MoLFormerEmbed`:
> - MoLFormer DEFAULT per L2.2 §3.2 BINDING
> - Drug SMILES → embedding; cached per drug"

There is NO mention of RDKitMoLFormerBaseline or any analogous parameter-free comparator for Slot 2. L4.1 lists 6 sub-slot deliverables (4.3 through 4.7); none correspond to Slot 2's matched-pair baseline.

### 2.3 Impact

If Layer 5 follows L4.1 verbatim, it builds Slot 2 without the BINDING RDKit baseline. At Stage 7 V0+V1, the Souza-Mehta matched-budget Decision 8 v2 Commitment 5 enforcement would have to retroactively scramble to add a Slot 2 baseline. This is exactly the kind of rework P3 (research before code) is meant to prevent.

### 2.4 Recommended Action

**L4.1 cleanup:** add deliverable 4.3a to Stage 4:
- `intercepta.l7.slots.molformer_baseline.RDKitFingerprintBaseline`
- Morgan + Avalon + MACCS fingerprints + linear classifier head
- BINDING per Decision 8 v2 Commitment 5 ≥25% MoLFormer hyperparameter budget
- Trained in matched pair with MoLFormer; comparison logged to MLflow per L4.1 §10.1

### 2.5 Severity Justification

MEDIUM (not HIGH) because Souza-Mehta enforcement is already in L3.1 + L3.2 + L3.3 + L4.2 (matched-pair test in §3.8). The missing Stage 4 deliverable would be caught by downstream specs but causes 2-4 weeks of rework if not fixed before Layer 5.

---

## §3 Drift Finding D13 — Ensemble Seed Inconsistency

### 3.1 What L2.2 Specifies (Spec-Level)

L2.2 §347 — the L7EnsembleConfig dataclass:
```python
ensemble_random_seeds: List[int] = field(default_factory=lambda: [0, 1, 2, 3, 4])
```

Seeds: 0, 1, 2, 3, 4.

### 3.2 What L4.1 + L4.2 Specify

L4.1 §5.2 Stage 4 deliverable 4.2:
> "BINDING per Drift Finding 8: ensemble seeds {42, 1337, 2023, 9, 31337}; per-head saved separately"

L4.1 §10.3 Reproducibility:
> "All ensemble seeds BINDING per Drift Finding 8 {42, 1337, 2023, 9, 31337}"

L4.2 §2.5 + §3.4:
> "ensemble seeds {42, 1337, 2023, 9, 31337} BINDING per Drift Finding 8"

Seeds: 42, 1337, 2023, 9, 31337.

### 3.3 The Contradiction

The two seed lists are entirely disjoint. If Layer 5 implements L2.2 verbatim (config defaults to [0,1,2,3,4]), the L4.2 reproducibility test that checks {42, 1337, 2023, 9, 31337} fails — blocking Stage 4 handoff.

If Layer 5 implements L4.1's seeds, it deviates from L2.2 spec — Layer 5 code does not match the spec.

### 3.4 Root Cause Analysis

The transcript summary indicates "Drift Finding 8 BINDING" was referenced. The actual Decision 5 v2 / Drift Finding 8 only requires "N=5 Deep Ensembles for the L7 head as ensembled unit" — it does NOT specify which seeds. The {42, 1337, 2023, 9, 31337} specific values appear to have been introduced in L4.1 and propagated to L4.2 as a "BINDING per Drift Finding 8" attribution, but Drift Finding 8 does not actually bind specific seed values.

### 3.5 Impact

HIGH. Layer 5 cannot satisfy both specs simultaneously. Reproducibility-by-seed is a Charter §1.3 falsifiability requirement; the test will fail; Stage 4 cannot hand off; entire downstream cascade blocked.

### 3.6 Recommended Action

**Resolve which seed list is canonical:**

**Option A (CSO-recommended):** Amend L2.2 §347 to match L4.1: `ensemble_random_seeds: List[int] = field(default_factory=lambda: [42, 1337, 2023, 9, 31337])`. These seeds are more "distinctive" (e.g., 1337 is well-known; 31337 is the elite variant) and are easier to verify in checkpoint filenames. Reasoning: L2.2 [0,1,2,3,4] is the "naive default"; L4.1 explicitly assigned the "distinctive seeds" to make checkpoint paths visually inspectable.

**Option B:** Amend L4.1 + L4.2 to match L2.2's [0,1,2,3,4]. Update both specs to remove the "Drift Finding 8 BINDING" attribution since Drift Finding 8 doesn't actually bind specific seeds.

**Option C:** Make seeds a config knob (not BINDING in either spec) and update reproducibility tests to check that whatever seeds are configured produce reproducible results (rather than checking for specific values). This is most flexible but loses some auditability.

**CSO recommendation: Option A.** Amend L2.2 to {42, 1337, 2023, 9, 31337}. Rationale: distinctive seeds aid auditability; the {42, 1337, ...} list is already cited in two downstream specs and a test fixture; L2.2 is the easier of the three to amend.

### 3.7 Severity Justification

HIGH because (a) blocks Stage 4 handoff, (b) Charter §1.3 falsifiability infrastructure depends on the resolution, (c) Drift Finding 8 attribution is incorrectly stated and needs correction in two specs regardless of which seeds are canonical.

---

## §4 Drift Finding D14 — Missing EVA-60M Substrate Adapter

### 4.1 What L3.3 Requires

L3.3 §3.2 paradigm B:

> "**Paradigm B — Disease-Area-Specific FM**
> **Substrate per disease:**
> - UC → EVA-60M (Bandasack 2026 demonstrated on UC anti-TNF)
> - AD → scFoundation-AD-specialized OR re-pretrain on Mathys cohort scRNA-seq (lightweight)
> - T2D → scFoundation-T2D-specialized OR re-pretrain on HPAP"

L3.3 §6.1 cell-level pass/fail BINDING explicitly evaluates paradigm B. Without an EVA-60M adapter, paradigm B (UC) cannot run at V6.

### 4.2 What L4.1 Stage 3 Specifies

L4.1 §4.2 Stage 3 deliverables list exactly 4 substrate adapters:
- 3.1 `intercepta.substrates.base.SubstrateInterface`
- 3.2 `intercepta.substrates.scvi.SCVISubstrate`
- 3.3 `intercepta.substrates.sctop.SCTOPSubstrate`
- 3.4 `intercepta.substrates.fm.FMSubstrate` (scFoundation-100M default)
- 3.5 `intercepta.substrates.pca_hvg.PCAHVGSubstrate`

NO EVA-60M, AD-specialized FM, or T2D-specialized FM adapter listed.

### 4.3 Impact

At Stage 8 (V6 cross-disease) the SLURM array would try to evaluate paradigm B for each disease, but the substrate adapter for paradigm B doesn't exist. Either Stage 8 silently skips paradigm B (violating Decision 8 v2 Commitment 2's "all 4 paradigms" BINDING) or Stage 8 fails when paradigm B is invoked.

### 4.4 Root Cause Analysis

L2.1 §11.3 says:

> "Disease-area-specialized FM integration. EVA-60M (Q8 anchor 4 per open source landscape) provides disease-area-specialized representation for I&I deployments. Per Decision 1 v2: 'This is a Paradigm B question per Decision 8, not a Decision 1 v2 commitment.' L2.1 makes EVA-60M integrable via the same SubstrateInterface but does not commit to its use."

L2.1 explicitly defers the EVA-60M commitment to "Paradigm B per Decision 8." L3.3 makes that commitment. L4.1's Stage 3 deliverables list was written before L3.3 was complete, so the deliverable list did not pick up the L3.3 commitment.

### 4.5 Recommended Action

**L4.1 amendment:** add Stage 3 deliverable 3.6:
- `intercepta.substrates.eva.EVA60MSubstrate` (for V6 paradigm B UC)
- Loads Hugging Face Scienta-Lab EVA-60M open variant
- BINDING per L3.3 §3.2 paradigm B commitment

For AD-specialized and T2D-specialized FM substrates: L3.3 says "OR re-pretrain on Mathys / HPAP (lightweight)" — these can be deferred to Stage 8 as part of V6-specific work since they don't require new architecture, just re-pretraining of scFoundation. Decision deferred to Stage 8 prep.

### 4.6 Severity Justification

HIGH because (a) blocks Stage 8 V6 paradigm B evaluation, (b) violates Decision 8 v2 Commitment 2 BINDING all-4-paradigms requirement, (c) catches an L3.3 commitment that L4.1 didn't pick up.

---

## §5 Drift Finding D15 — Decision 2 v2 Harmonization Deferred but V1 Depends

### 5.1 What L3.1 V1 Assumes

L3.1 §12 Cross-Decision Implications:

> "Decision 2 v2 (Harmonization): Cohort harmonization upstream; L3.1 inherits harmonized data."

V1 cross-dataset evaluation (GDSC↔CCLE↔CTRP) explicitly depends on Decision 2 v2 harmonization producing data that crosses dataset boundaries without spurious batch effects.

### 5.2 What L4.1 Stage 2 Specifies

L4.1 §3.2 Stage 2 deliverable 2.3:

> "**2.3 `intercepta.data.harmonization` (Decision 2 v2 minimal Phase B placeholder):**
> - Light wrapper around scvi-tools' integration; INTEGRATION method default per L2.1
> - **NOT the full Decision 2 v2 specification (that's Layer 5 + future Layer 4 spec)**"

L4.1 explicitly defers "the full Decision 2 v2 specification" to a future Layer 4 spec.

### 5.3 Impact

Whether the "minimal Phase B placeholder" is sufficient for V1 IMPROVE methodology cross-dataset evaluation is empirically unknown. If the placeholder produces enough harmonization to satisfy V1 (mean AUROC ≥ 0.65 + IMPROVE match), the deferral is fine. If not, Stage 7 V1 fails for harmonization reasons (F2 cross-platform batch effect per L4.3) that an amended Decision 2 v2 spec would have prevented.

### 5.4 Recommended Action

**Option A (CSO-recommended):** Accept the deferral with explicit Stage 2 handoff criterion addition:

> "Stage 2 § handoff criterion (new): Minimal harmonization placeholder produces V1 AUROC ≥ 0.65 on at least 3 of 6 cross-pairs OR Decision 2 v2 deep spec is scheduled before Stage 7 V1 launches."

This adds a checkpoint: if the placeholder is insufficient, the deep spec gets written before Layer 5 burns budget on a failing V1.

**Option B:** Write the Decision 2 v2 deep spec now (before Layer 5 starts) as a 4th Layer 4 artifact "L4.4 Cross-Cohort Harmonization Specification." This adds ~4-6K words and one more session.

**Option C:** Accept full risk; let V1 surface the issue empirically.

**CSO recommendation: Option A.** Adds 1 sentence to L4.1; preserves option of writing L4.4 if Stage 7 V1 needs it without committing to do so prematurely.

### 5.5 Severity Justification

LOW because (a) Decision 2 v2 placeholder MAY be sufficient for V1 — empirical question, (b) impact is delayed (Stage 7, not Stage 2), (c) the recommended Option A mitigation is a single sentence in L4.1.

---

## §6 Summary of Recommended Cleanup Actions

Before Layer 5 starts:

| Drift | Action | Spec | Effort |
|---|---|---|---|
| D12 | Add RDKit Slot 2 baseline as Stage 4 deliverable 4.3a | L4.1 amendment | ~30 minutes |
| D13 | Amend L2.2 §347 to use {42, 1337, 2023, 9, 31337} OR amend L4.1+L4.2 to use [0,1,2,3,4]; resolve "Drift Finding 8 BINDING" attribution | L2.2 (Option A) OR L4.1+L4.2 (Option B) | ~30 minutes |
| D14 | Add EVA-60M adapter as Stage 3 deliverable 3.6 | L4.1 amendment | ~30 minutes |
| D15 | Add Stage 2 handoff criterion: minimal harmonization sufficient for V1 OR Decision 2 v2 spec scheduled | L4.1 amendment | ~15 minutes |

**Total cleanup time:** ~2 hours of focused spec editing across L4.1 (+ optionally L2.2).

After cleanup → re-run audit Pass 1 (BINDING inventory) and Pass 3 (schema coherence) to verify resolution → Phase 8 Audit COMPLETE → Layer 5 STAGE 1 begins.

---

## §7 Audit Pass-by-Pass Status

| Pass | Focus | Status |
|---|---|---|
| 1 | BINDING constraint inventory | D13 detected (seed inconsistency) |
| 2 | Cross-decision implications symmetry | CLEAN |
| 3 | Schema and interface coherence | D14 detected (EVA-60M missing) |
| 4 | CSO judgment item escalation review | CLEAN (J-items consistently distributed) |
| 5 | Compute envelope arithmetic | CLEAN (174-224 within 200-300 envelope) |
| 6 | Test coverage completeness | D12 detected (Slot 2 baseline) |
| 7 | Failure mode coverage | CLEAN (all L4.1 handoff failures map to L4.3 codes) |
| 8 | Charter principle compliance | D15 detected (Decision 2 v2 deferral risk) |

**Overall: 4 findings (D12-D15); 4 clean passes.**

---

## §8 Verdict and Next Steps

### 8.1 Verdict

**PROVISIONAL PASS WITH CLEANUP REQUIRED.**

The 10 Phase B specs are architecturally sound on major BINDING constraints (Souza-Mehta, V3-V6 thresholds, schema coherence, compute envelope, Phase F discipline, Charter principle compliance). The 4 drift findings (D12-D15) are localized cleanup issues that can be resolved in ~2 hours of focused spec editing.

**Layer 5 Stage 1 (Foundation) should NOT begin until D12-D15 are resolved.**

### 8.2 CEO Decision Required

The CEO must decide:

1. **D12 cleanup:** approve adding RDKit Slot 2 baseline to L4.1 Stage 4? (CSO recommends YES)
2. **D13 resolution:** Option A (amend L2.2 to {42, 1337, 2023, 9, 31337}) or Option B (amend L4.1+L4.2 to [0,1,2,3,4])? (CSO recommends Option A)
3. **D14 cleanup:** approve adding EVA-60M adapter to L4.1 Stage 3? (CSO recommends YES)
4. **D15 mitigation:** Option A (add Stage 2 handoff criterion) or Option B (write L4.4 Decision 2 v2 spec now) or Option C (accept full risk)? (CSO recommends Option A)

After CEO decisions, CSO executes the 4 cleanup actions; audit re-validates resolution.

### 8.3 Critical Reminder

The drift findings are NOT specification failures — they are exactly what an audit is supposed to catch. The 2026-05-11 Charter v1.2 audit surfaced 11 findings on a similar corpus; finding 4 here on a 71K-word multi-session corpus is consistent with realistic engineering discipline. **The system caught its own drift before code started. P3 honored.**

### 8.4 What Comes After Cleanup

After D12-D15 resolved + audit Pass 1 + Pass 3 re-run + verdict confirmed CLEAN:

1. **Phase 8 Audit COMPLETE**
2. **Layer 5 Stage 1 (Foundation) begins:** repo + env + CI + Explorer onboarding + MLflow per L4.1 §2
3. First empirical V0 result emerges at Stage 7 Day 1 (per L4.1 §8.5)
4. Phase B Layer 5 COMPLETE at Stage 8 end (V6 verdict)
5. Phase B → Phase F transition per Charter v1.2 §1.7

### 8.5 Drift Catalog This Audit

| ID | Type | First Detected | Status |
|---|---|---|---|
| D1-D11 | Charter v1.1 → v1.2 reconciliation drift | 2026-05-11 audit | RESOLVED (Charter v1.2 LOCKED) |
| **D12** | L4.1 Stage 4 missing Slot 2 baseline | 2026-05-11 Phase 8 audit | OPEN — requires CEO decision |
| **D13** | Ensemble seed inconsistency L2.2 vs L4.1/L4.2 | 2026-05-11 Phase 8 audit | OPEN — requires CEO decision |
| **D14** | L4.1 Stage 3 missing EVA-60M adapter | 2026-05-11 Phase 8 audit | OPEN — requires CEO decision |
| **D15** | Decision 2 v2 deferral vs V1 dependency | 2026-05-11 Phase 8 audit | OPEN — requires CEO decision |

---

## §9 Provenance

### 9.1 Provenance

Phase 8 Audit conducted by Claude (CSO, 2026-05-11). 8-pass methodology executed on all 10 Phase B Layer 2-4 specs. No new architecture proposed; only audit findings surfaced. Pattern consistent with 2026-05-11 Charter v1.2 audit that surfaced D1-D11.

### 9.2 Discipline Check Per Charter v1.2 Principles

- **P3 (research before code):** ✅ AUDIT IS P3 OPERATIONAL — surfacing drift before code begins is exactly P3 in action
- **P15 (only honest science):** ✅ §1.3 "what the audit did NOT find" honestly listed; severity ratings honest
- **P16 (preserve past work):** ✅ audit does not modify any spec; only proposes amendments via CEO decision
- **Charter §5.3:** ✅ §8.1 verdict explicit; §8.2 CEO decisions enumerated

### 9.3 Files Audited

Located at `/mnt/user-data/outputs/`:
- INTERCEPTA_FV_L2_1_Substrate_Architecture_Specification_2026-05-11.md
- INTERCEPTA_FV_L2_2_L7_Drug_Response_Architecture_Specification_2026-05-11.md
- INTERCEPTA_FV_L2_3_OOD_Detection_Stack_Specification_2026-05-11.md
- INTERCEPTA_FV_L2_4_Mechanistic_Interpretability_Architecture_Specification_2026-05-11.md
- INTERCEPTA_FV_L3_1_V0_V6_Validation_Cascade_Pipeline_Specification_2026-05-11.md
- INTERCEPTA_FV_L3_2_56_Pass_Criteria_Specification_2026-05-11.md
- INTERCEPTA_FV_L3_3_Cross_Disease_V6_Grid_Specification_2026-05-11.md
- INTERCEPTA_FV_L4_1_Implementation_Order_Specification_2026-05-11.md
- INTERCEPTA_FV_L4_2_Testing_Specification_2026-05-11.md
- INTERCEPTA_FV_L4_3_Failure_Modes_Specification_2026-05-11.md

### 9.4 Audit File Path

This report: `~/INTERCEPTA/docs/research/phase_b/INTERCEPTA_Phase_B_Phase_8_Audit_Report_2026-05-11.md`

---

— Phase 8 Audit CONDUCTED 2026-05-11 by Claude (CSO).
— Verdict: PROVISIONAL PASS WITH 4 DRIFT FINDINGS (D12-D15) requiring CEO decisions + cleanup before Layer 5 Stage 1 begins.
— After D12-D15 cleanup + audit re-validation → Phase 8 Audit COMPLETE → Layer 5 STAGE 1 (Foundation) starts.
